Medicine
Vasopressin 20 units/mL injection
Vasopressin 20 units/mL injection is a generic prescription medicine for intravenous use, made by 11 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Once removed from refrigeration, mark the unopened vial with the revised…
Key facts
- Active ingredient (INN)
- Vasopressin
- Brand
- Sold under the generic name
- Strength
- 20 units/mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 vial, 25 vials, 10 vials and 16 more
- Manufacturers
- EugiaIndiaGland PharmaIndiaAmneal PharmaceuticalsAmerican RegentFresenius KabiHealthFirstAmphastar PharmaceuticalsCivicaMedical Purchasing SolutionsProPharma Distribution
- Origin register
- US FDA, United States
- Storage
- Once removed from refrigeration, mark the unopened vial with the revised 12-month expiration date. Do not return Vasopressin to the refrigerator after it has been stored at room temperature. is permitted for up to 12 months at controlled room temperature (USP) 20°C to 25°C (68°F to 77°F) within the expiry date.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- H01BA01 Vasopressin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 3 February 2022
- Identifiers
- RxCUI 313578, 2103182, 2399907DailyMed set ID 0ab267f4-9ec9-44fd-8521-f975074667d9, d9869345-b02c-4225-a97b-656f14c86dec, eadd82d7-e2cb-4144-9f0c-b340f54c6fa4 +11NDC 0517-1020, 0517-1030, 70121-1642 +11Application NDA212593, ANDA212944, ANDA214314 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, multi-dose in 1 carton / 1 mL in 1 vial, multi-dose | 55150-370-01 | EugiaIndia | 15 August 2022 |
| 25 vial, multi-dose in 1 carton / 1 mL in 1 vial, multi-dose | 55150-370-24 | EugiaIndia | 15 August 2022 |
| 25 vial, multi-dose in 1 carton / 1 mL in 1 vial, multi-dose | 55150-370-25 | EugiaIndia | 15 August 2022 |
| 10 vial in 1 carton / 1 mL in 1 vial | 68083-520-10 | Gland PharmaIndia | 9 February 2024 |
| 25 vial in 1 carton / 1 mL in 1 vial | 68083-520-25 | Gland PharmaIndia | 9 February 2024 |
| 25 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 0517-1020-25 | American Regent | 3 February 2022 |
| 1 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 0517-1030-01 | American Regent | 21 June 2023 |
| 25 vial, single-dose in 1 tray / 1 mL in 1 vial, single-dose | 63323-930-01 | Fresenius Kabi | 26 May 2023 |
| 25 vial, single-dose in 1 tray / 1 mL in 1 vial, single-dose | 65219-039-01 | Fresenius Kabi | 26 May 2023 |
| 1 vial in 1 carton / 1 mL in 1 vial | 70121-1642-2 | Amneal Pharmaceuticals | 11 August 2022 |
| 25 vial in 1 carton / 1 mL in 1 vial | 70121-1642-5 | Amneal Pharmaceuticals | 11 August 2022 |
| 10 vial in 1 carton / 1 mL in 1 vial | 70121-1642-7 | Amneal Pharmaceuticals | 11 August 2022 |
| 1 vial in 1 carton / 1 mL in 1 vial | 0548-9701-00 | Amphastar Pharmaceuticals | 31 August 2022 |
| 25 vial in 1 carton / 1 mL in 1 vial | 25021-474-01 | Sagent Pharmaceuticals | 15 November 2024 |
| 1 vial in 1 pouch / 10 mL in 1 vial | 51662-1682-2 | HealthFirst | 21 June 2023 |
| 1 vial in 1 pouch / 1 mL in 1 vial | 51662-1688-2 | HealthFirst | 3 February 2022 |
| 25 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 72572-860-25 | Civica | 22 October 2025 |
| 1 vial, multi-dose in 1 bag / 1 mL in 1 vial, multi-dose | 71872-7306-1 | Medical Purchasing Solutions | 10 August 2023 |
| 1 mL in 1 vial, multi-dose | 84549-370-25 | ProPharma Distribution | 27 August 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 17 April 2014 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Vasopressin
Clinical summary
Vasopressin is a prescription medicine indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines. It is available as injection for intravenous use. MedsAcross supplies Vasopressin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about VasopressinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Vasopressin prescribing information (Civica) · U.S. National Library of Medicine, DailyMed
Need Vasopressin 20 units/mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.